CellProthera is a startup based in France, 1 tracked investor.
Based in France, CellProthera is a startup. Brouky records 1 investor associated with the company.
CellProthera is a clinical-stage biotechnology company developing a unique cell therapy for the regeneration of damaged heart tissue following acute myocardial infarction. Their lead product is currently in Phase I/IIb clinical trials.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.